Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms
Jacques A. J. Malherbe(The University of Western Australia), Wendy N. Erber(The University of Western Australia)
Cited by 30
Related Papers
Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms
|British Journal of Haematology|2009|76
TGFα expression in myeloid malignancies
|Journal of Clinical Pathology|2016|5